Fig. 2From: LYL1 gene amplification predicts poor survival of patients with uterine corpus endometrial carcinoma: analysis of the Cancer genome atlas dataSurvival outcomes of patients with uterine corpus endometrial carcinoma, shown by LYL1 gene status: a overall survival and (b) progression-free survivalBack to article page